middle.news
How Clarity’s $203M Raise Could Transform Prostate Cancer Diagnostics and Therapy
9:37am on Tuesday 25th of November, 2025 AEDT
•
Healthcare
Read Story
How Clarity’s $203M Raise Could Transform Prostate Cancer Diagnostics and Therapy
9:37am on Tuesday 25th of November, 2025 AEDT
Key Points
Raised $203 million to fund clinical development and manufacturing
Multiple Phase II and III trials targeting prostate cancer and neuroendocrine tumors
Three FDA Fast Track Designations granted for diagnostic and therapeutic indications
Robust US-based supply chain and manufacturing partnerships secured
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CU6
OPEN ARTICLE